Evidence map›Paper›PMID 37645908›Full record

ArticlebioRxiv : the preprint server for biology2023

SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels.

Natalia Eberhardt, Maria Gabriela Noval, Ravneet Kaur, Swathy Sajja, Letizia Amadori, Dayasagar Das, Burak Cilhoroz, O'Jay Stewart, Dawn M Fernandez, Roza Shamailova and 13 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 16 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 2 countries.

Natalia Eberhardt
Maria Gabriela Noval
Ravneet Kaur
Swathy Sajja
Letizia Amadori
Dayasagar Das
Burak Cilhoroz
O'Jay Stewart
Dawn M Fernandez
Roza Shamailova
Andrea Vasquez Guillen
Sonia Jangra
Michael Schotsaert
Michael Gildea
Jonathan D Newman
Peter Faries
Thomas Maldonado
Caron Rockman
Amy Rapkiewicz
Kenneth A Stapleford
Navneet Narula
Kathryn J Moore
Chiara GiannarelliORCID 0000-0003-2473-6058
New York University · USIcahn School of Medicine at Mount Sinai · USNYU Langone Health · USUniversity School · USCardiovascular Research Center · BRWinthrop-University Hospital · US

Funding

Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacyR01AI160706 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHOTSAERT, MICHAEL, WONG, PAMELA TINMOI · 2022 to 2025
$2.9M
NIAID NIH HHS R01 AI160706
6 · The paper itself

Abstract

COVID-19 patients present higher risk for myocardial infarction (MI), acute coronary syndrome, and stroke for up to 1 year after SARS-CoV-2 infection. While the systemic inflammatory response to SARS-CoV-2 infection likely contributes to this increased cardiovascular risk, whether SARS-CoV-2 directly infects the coronary vasculature and attendant atherosclerotic plaques to locally promote inflammation remains unknown. Here, we report that SARS-CoV-2 viral RNA (vRNA) is detectable and replicates in coronary atherosclerotic lesions taken at autopsy from patients with severe COVID-19. SARS-CoV-2 localizes to plaque macrophages and shows a stronger tropism for arterial lesions compared to corresponding perivascular fat, correlating with the degree of macrophage infiltration.

Identifiers

PMID37645908
PMCPMC10461985
OpenAlexW4385875854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.